By fusing enzyme fragments to antibodies, researchers from the Institute of Science Tokyo, in Japan, developed an innovative ...

The TL1a inhibitor duvakitug was effective at 14 weeks in patients who had previous exposure to conventional and advanced ...

They're just one-tenth the size of conventional antibodies, and have not been found in any other mammals, say scientists.

New research comparing four different flu vaccines found that the ability of the vaccines to activate cells of the immune ...

Artificial intelligence (AI) and "protein language" models can speed the design of monoclonal antibodies that prevent or ...

Initial clinical data for BDC-4182 Phase 1 dose escalation study expected in 3Q 2026  Cash balance of $38.8 million as of September 30, 2025 anticipated to fund key milestones into 2027 REDWOOD CITY, ...

Prior exposure to coronaviruses that cause ordinary colds can boost the immune system's ability to attack a vulnerable site ...

New research comparing four different flu vaccines found that the ability of the vaccines to activate cells of the immune system that help to protect against infection varied greatly depending on the ...

Breast cancer advancements include targeted therapies, oral medications for ER-positive/HER2-negative populations, and ...

More severe symptoms of RSV include rapid breathing, difficulty breathing such as babies flaring their nostrils, ribs sucking ...

In this video, Paolo Strati, MD, discusses the potential of bispecific antibody and antibody-drug conjugate combination ...

Research led by the University of Washington reports on an AI-guided method that designs epitope-specific antibodies and ...